Financials data is unavailable for this security.
View more
Year on year Vaidya Sane Ayurved Laboratories Ltd grew revenues 32.55% from 747.11m to 990.25m while net income improved 49.61% from 34.69m to 51.90m.
| Gross margin | 71.79% |
|---|---|
| Net profit margin | 3.47% |
| Operating margin | 3.65% |
| Return on assets | 6.04% |
|---|---|
| Return on equity | 7.77% |
| Return on investment | 7.39% |
More ▼
Cash flow in INRView more
In 2023, cash reserves at Vaidya Sane Ayurved Laboratories Ltd fell by 8.09m. However, Cash Flow from Investing totalled 10.00m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 4.29m for operations while cash used for financing totalled 13.80m.
| Cash flow per share | 6.34 |
|---|---|
| Price/Cash flow per share | 23.65 |
| Book value per share | 52.12 |
|---|---|
| Tangible book value per share | 45.62 |
More ▼
Balance sheet in INRView more
| Current ratio | 2.85 |
|---|---|
| Quick ratio | 2.57 |
| Total debt/total equity | 0.0733 |
|---|---|
| Total debt/total capital | 0.0683 |
More ▼
Growth rates in INR
Year on year, growth in earnings per share excluding extraordinary items increased 49.57%.
| Div yield(5 year avg) | 0.04% |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 7.24% |
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -25.05 |
More ▼
